HOST-VIRUS INTERACTIONS AT THE CELLULAR LEVEL
细胞水平上的宿主-病毒相互作用
基本信息
- 批准号:8470003
- 负责人:
- 金额:$ 26.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-02-01 至 2018-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntiviral AgentsAreaAsthmaBasic ScienceBiologyBiopsyBronchiolitisBronchitisCell Culture TechniquesCell DensityCellsCharacteristicsChronic lung diseaseClinicalClinical ResearchColorCommon ColdComplexDataDevelopmentEnvironmentEpithelial CellsGene ExpressionGrowthHeterogeneityHumanImageImmuneInfectionInstructionIntegration Host FactorsKnowledgeLeadLower Respiratory Tract InfectionMeasuresMethodsMolecularPatientsPopulationPredispositionProductionReporterResourcesRespiratory Tract InfectionsRhinovirusSamplingSeverity of illnessSignal TransductionSymptomsTechnologyTestingTimeTissuesUpper respiratory tractViralVirusVirus DiseasesVirus-Cell Membrane InteractionWheezingWorkcell behaviorexperienceextracellularimprovedin vivoinsightnew technologynovelnovel strategiesparticlerespiratoryresponsestandard measuretooltreatment strategyvirus host interaction
项目摘要
PROJECT SUMMARY (See instructions): Infections by human rhinovirus (HRV) contribute to a diversity of human illnesses that include the common cold, bronchitis, exacerbation of asthma and other chronic lung diseases. Patient biopsies of HRV-infected tissues from the upper and lower airways reveal patches of robust infection dispersed among areas of healthy tissue. We hypothesize that differing tissue susceptibility to HRV infection reflects an underlying and intrinsic cell-level heterogeneity in responses to virus infection and antiviral immune signals. Testing this hypothesis poses a number of challenges: standard measures of cell behavior sampled from large cell populations provide an average, not single-cell measures; spreading infections are by definition complex and heterogeneous environments; and most mechanistic studies of viral growth and infection spread lack host factors that potentially promote virus spread. To address these challenges we will build on our significant experience measuring single-cell infections, as well as implementing and quantifying infection spread in controlled cell-culture environments. We propose to employ: (i) a dual-color fluorescent reporter method to provide simultaneous readouts of viral and cellular gene expression from HRV-infected cells, (ii) a quantitative imaging acquisition and analysis platform for high-throughput measures of dynamic single-cell behaviors, and (iii) a micro-scale cell-culture technology that offers unprecedented environmental control over cell density, localized virus inoculation, and flow conditions. Preliminary results indicate the feasibility of these technologies and significant opportunity for elucidating mechanisms of viral and cellular gene expression, virus growth, and infection spread. Our project aims to: (1) advance a data-driven integrated understanding of HRV single-cycle growth in cell cultures, (2) elucidate the impact of cell-virus interactions on HRV infection spread, and (3) isolate, characterize and utilize host factors that promote growth and spread of HRV in vivo. These aims will make extensive use of molecular and clinical tools in the other two projects, including airway epithelial cells and chimeric viruses. Results from this project will provide novel insights into how some tissues resist infection while others are susceptible, and this information will guide the development of improved treatment strategies for HRV-related illnesses.
项目摘要(参见说明):人鼻病毒 (HRV) 感染会导致多种人类疾病,包括普通感冒、支气管炎、哮喘恶化和其他慢性肺部疾病。对患者上呼吸道和下呼吸道感染 HRV 的组织进行活组织检查,发现健康组织区域中散布着严重的感染斑块。我们假设不同的组织对 HRV 感染的易感性反映了对病毒感染和抗病毒免疫信号反应的潜在和内在的细胞水平异质性。测试这一假设提出了许多挑战:从大细胞群中采样的细胞行为的标准测量提供了平均而非单细胞测量;根据定义,传播感染是复杂且异构的环境;大多数关于病毒生长和感染传播的机制研究缺乏可能促进病毒传播的宿主因素。为了应对这些挑战,我们将利用测量单细胞感染以及在受控细胞培养环境中实施和量化感染传播的丰富经验。我们建议采用:(i)双色荧光报告方法,同时读取 HRV 感染细胞的病毒和细胞基因表达,(ii)定量成像采集和分析平台,用于动态单通道高通量测量细胞行为,以及(iii)微型细胞培养技术,可对细胞密度、局部病毒接种和流动条件提供前所未有的环境控制。初步结果表明这些技术的可行性以及阐明病毒和细胞基因表达、病毒生长和感染传播机制的重要机会。我们的项目旨在:(1) 推进对细胞培养物中 HRV 单周期生长的数据驱动综合理解,(2) 阐明细胞-病毒相互作用对 HRV 感染传播的影响,以及 (3) 分离、表征和利用促进 HRV 在体内生长和传播的宿主因素。这些目标将在其他两个项目中广泛使用分子和临床工具,包括气道上皮细胞和嵌合病毒。该项目的结果将为了解某些组织如何抵抗感染而另一些组织如何易感提供新的见解,并且这些信息将指导开发针对 HRV 相关疾病的改进治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Yin其他文献
John Yin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Yin', 18)}}的其他基金
Flow-enhanced characterization of drug-resistant viruses
耐药病毒的流式增强表征
- 批准号:
7871430 - 财政年份:2008
- 资助金额:
$ 26.44万 - 项目类别:
Flow-enhanced characterization of drug-resistant viruses
耐药病毒的流式增强表征
- 批准号:
8136758 - 财政年份:2008
- 资助金额:
$ 26.44万 - 项目类别:
Flow-enhanced characterization of drug-resistant viruses
耐药病毒的流式增强表征
- 批准号:
7347135 - 财政年份:2008
- 资助金额:
$ 26.44万 - 项目类别:
相似国自然基金
基于激发植物免疫为导向的嘧啶酮类高效抗病毒剂设计合成及作用机制研究
- 批准号:21807037
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
云南地方晾晒烟中的内源性抗烟草花叶病毒活性成分研究
- 批准号:31860100
- 批准年份:2018
- 资助金额:41.0 万元
- 项目类别:地区科学基金项目
两种植物中抗烟草花叶病毒先导化合物的结构优化、构效关系及作用机制研究
- 批准号:31760089
- 批准年份:2017
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
基于kealiinine类海洋生物碱的新型抗病毒剂的设计合成、构效关系及作用机制研究
- 批准号:21772145
- 批准年份:2017
- 资助金额:64.0 万元
- 项目类别:面上项目
生态农药的分子设计与作用机制
- 批准号:21732002
- 批准年份:2017
- 资助金额:300.0 万元
- 项目类别:重点项目
相似海外基金
Defining the impact of complement inhibition by tick saliva in tick-borne virus evolution and adaptive immune responses in murine models of infection
定义蜱唾液抑制补体对蜱传病毒进化和小鼠感染模型适应性免疫反应的影响
- 批准号:
10535945 - 财政年份:2023
- 资助金额:
$ 26.44万 - 项目类别:
An L-Aptamer-Displacement Assay for High-Throughput Screening of RNA-Targeted Small Molecule Antivirals
用于高通量筛选 RNA 靶向小分子抗病毒药物的 L 适体置换测定
- 批准号:
10648368 - 财政年份:2023
- 资助金额:
$ 26.44万 - 项目类别:
IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023
IAS 2023,第 12 届 IAS HIV 科学会议,澳大利亚布里斯班,虚拟会议,2023 年 7 月 23-26 日
- 批准号:
10696505 - 财政年份:2023
- 资助金额:
$ 26.44万 - 项目类别:
Dissecting the drivers of persistent SARS-CoV-2 infections
剖析 SARS-CoV-2 持续感染的驱动因素
- 批准号:
10736007 - 财政年份:2023
- 资助金额:
$ 26.44万 - 项目类别:
High throughput screening and drug discovery for antagonists of the Ebola VP40 protein assembly
埃博拉 VP40 蛋白组装拮抗剂的高通量筛选和药物发现
- 批准号:
10760573 - 财政年份:2023
- 资助金额:
$ 26.44万 - 项目类别: